APRIL levels were also higher in patients with ALL and a WBC count of >50 × 109/L (p = 0.002) and the risk group (28.3–47.8 ng/mL, p = 0.013). This evidence concerns the gene TNFSF13 and acute lymphoblastic leukemia.